Novartis India
BSE: 500672 | NSE: NOVARTIND | ISIN: INE234A01025 | Pharmaceuticals
 |
Quarterly Results of Novartis India |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Sep '08 | Dec '08 | Mar '09 | Jun '09 | Sep '09 | ||||||
|
||||||||||
| Sales Turnover | 154.49 | 159.90 | 137.87 | 161.24 | 169.03 | |||||
| Other Income | 18.58 | 14.86 | 12.63 | 10.87 | 10.63 | |||||
| Total Income | 173.07 | 174.76 | 150.50 | 172.11 | 179.66 | |||||
| Total Expenses | 121.73 | 132.95 | 114.87 | 121.19 | 128.64 | |||||
| Operating Profit | 32.76 | 26.95 | 23.00 | 40.05 | 40.39 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 51.34 | 41.81 | 35.63 | 50.92 | 51.02 | |||||
| Interest | 0.08 | 0.48 | 0.08 | 0.07 | 0.05 | |||||
| PBDT | 51.26 | 41.33 | 35.55 | 50.85 | 50.97 | |||||
| Depreciation | 0.65 | 0.65 | 0.68 | 0.56 | 0.56 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 50.61 | 40.68 | 34.87 | 50.29 | 50.41 | |||||
| Tax | 21.42 | 16.51 | 14.16 | 18.53 | 17.15 | |||||
| Net Profit | 29.19 | 24.17 | 20.71 | 31.76 | 33.26 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 9.13 | 7.56 | 6.48 | 9.94 | 10.41 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 15.98 | 15.98 | 15.98 | 15.98 | 15.98 | |||||
| Reserves | -- | -- | -- | -- | -- | |||||
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Novartis India connections | ||||||||||
| ||||||||||
